3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
4
Breast
4
Tumor-Agnostic
3
Thoracic
3
Gynecologic
2
Genitourinary
2
Other
1
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Conditions
Prostatic Neoplasms
31
Urinary Bladder Neoplasms
4
Carcinoma, Renal Cell
3
Neoplasms
2
Metabolic Syndrome
2
Lung Neoplasms
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Gain
1
Waldenstrom Macroglobulinemia
1
Urothelial Cancer
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Interventions
pembrolizumab
28
Docetaxel
21
Gemcitabine
19
Nivolumab
15
Paclitaxel
13
Prednisone
12
Leuprolide
11
pazopanib
10
Radiotherapy
10
Cisplatin
10
Sunitinib
9
Sorafenib
9
Ipilimumab
8
Blood Specimen Collection
8
Bevacizumab
8
avelumab
7
atezolizumab
7
Therapeutics
7
Thalidomide
7
Cyclophosphamide
7
Carboplatin
7
Standard of Care
6
Radiation
6
Mitomycin
6
Interleukin-2
6
Cetuximab
6
Axitinib
6
padeliporfin
5
enzalutamide
5
cemiplimab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Metformin
×
Genitourinary
×
Clear all
NCT05515978
2026-06-02
PragMet
University of Colorado, Denver
Phase EARLY_PHASE1
Recruiting
100 enrolled
NCT01864096
2024-01-24
MAST
University Health Network, Toronto
Phase 3
Unknown
408 enrolled